Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2023-09-25 Regulatory Filings
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Otrzymanie istotnych zleceń od dużej firmy farmaceutycznej / Receipt of significant purchase orders from a big pharma company - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a formal announcement from the Management Board ('Zarząd') of Selvita S.A. regarding receiving significant research service orders ('Zlecenia') from a major pharmaceutical client. It details the nature of the services (ADME/DMPK, PK studies), the value of the contracts (EUR 3.2 million), and the timeline for execution (through July 2024). This type of announcement, detailing a significant business contract or transaction that impacts the company's operations and future outlook, is best classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if it were about raising funds, but here it is about securing revenue-generating contracts. Since there is no specific category for 'Major Contract Award,' and it is a formal regulatory disclosure in Polish, RNS (Regulatory Filings) is the most appropriate fallback category for significant, non-standard operational news. The document length (1888 chars) is short, but it is the primary disclosure, not an announcement *about* a primary disclosure, so RPA is not applicable.
2023-09-25 Polish
Otrzymanie istotnego zlecenia przez spółkę zależną Selvita S.A. - Content (EN)
Regulatory Filings Classification · 95% confidence The document announces a significant new contract ('Order') received by a subsidiary of Selvita S.A. from a European biopharmaceutical company. It details the scope (conducting analyses of samples from a biologic drug purification process), the duration (8 months), and the value (ranging from 2.4M EUR to 3.6M EUR). This type of announcement, concerning a major business contract or transaction that impacts the company's operations and financial outlook, best fits the 'Capital/Financing Update' (CAP) or potentially 'Regulatory Filings' (RNS) if it were a mandatory disclosure in a specific jurisdiction. However, since it details a significant business transaction (a large contract award) rather than pure financing, and it is not a standard financial report (10-K, IR, ER), it most closely aligns with a material event disclosure. Given the options, and recognizing that major contract wins are often disclosed as significant corporate events, it doesn't perfectly fit the provided definitions. It is not a financing event (CAP), nor a management change (MANG), nor a legal issue (LTR). It is a disclosure of a major business development. In many regulatory contexts, such a material contract award disclosure falls under general significant event reporting. Since 'CAP' is for fundraising/financing, and no other category fits a major contract award, I will re-evaluate. This is a disclosure of a significant business contract. If this were a US filing, it might be an 8-K Item 1.01 (Entry into a Material Definitive Agreement). Among the provided codes, none explicitly cover 'Major Contract Award'. Given the options, and ruling out the others based on content (no financials, no management change, no dividend, no proxy), the closest fit for a significant, non-standard corporate event disclosure that isn't explicitly covered elsewhere is often grouped under general regulatory announcements or sometimes financing/capital structure changes if the contract implies future revenue streams or capital deployment. Since it is a specific, material business event disclosure, and not a standard report, 'RNS' (Regulatory Filings - fallback) is the safest general category, but let's check if 'CAP' could apply. CAP is for fundraising/financing/capital structure. This is a revenue-generating contract. Therefore, 'RNS' is the most appropriate fallback for a material, non-standard corporate announcement not covered by other specific codes.
2023-09-01 English
Otrzymanie istotnego zlecenia przez spółkę zależną Selvita S.A. - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a formal announcement from the Management Board ('Zarząd') of Selvita S.A. regarding a significant new contract ('Zlecenie') received by its subsidiary from a European biopharmaceutical company. The text details the nature of the work (analysis of samples for drug purification), the duration (8 months), and the substantial value of the contract (EUR 2.4M to EUR 3.6M). This type of announcement, detailing a major business contract or financing event, aligns best with the 'Capital/Financing Update' (CAP) category if it were about raising capital, or more generally, a significant business development. Since it is a major contract award, it is a material event. Given the options, this is a significant business development that impacts the company's operations and future revenue. It is not a standard financial report (10-K, IR, ER), a management change (MANG), or a director's trade (DIRS). It is a specific announcement of a material contract. While 'RNS' (Regulatory Filings) is a fallback, the content strongly suggests a material business contract announcement. In many regulatory contexts, major contract awards are disclosed as material information. Among the provided codes, 'CAP' (Capital/Financing Update) is sometimes used broadly for major financial commitments or significant revenue-generating contracts, but a more precise fit is often lacking for general material contract news. However, looking closely at the definitions, none perfectly capture 'Major Contract Award'. Since this is a disclosure of a significant business event that impacts future performance and financial standing, and it is not explicitly covered by other specific codes like M&A (TAR) or Share Issues (SHA), it falls under the general category of material regulatory disclosure. Given the context of Polish regulatory filings (where such announcements are common), and the lack of a specific 'Material Contract Award' code, 'RNS' (Regulatory Filings - general regulatory announcements) is the most appropriate fallback for a significant, non-standard disclosure that isn't a standard financial report or management change.
2023-09-01 Polish
Powiadomienie o transakcji
Director's Dealing Classification · 99% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of transaction(s) referred to in Article 19(1) of the MAR Regulation). Article 19 of the Market Abuse Regulation (MAR) mandates reporting of transactions conducted by persons discharging managerial responsibilities (PDMRs). The content details a transaction involving an executive ('Paweł Przewięźlikowski', Member of the Supervisory Board) of the issuer ('SELVITA S.A.'), specifying the instrument (shares), the nature of the transaction ('Wydanie Akcji w ramach Programu Motywacyjnego - darowizna' / Issuance of Shares under the Incentive Program - donation), volume, price, and date. This directly corresponds to the definition of Director's Dealing (insider trades by directors/executives).
2023-08-25 Polish
Powiadomienie od osoby pełniącej obowiązki zarządcze w Spółce w związku z realizacją Programu Motywacyjnego - art. 19 MAR / Notification from person discharging managerial responsibilities in the C...
Director's Dealing Classification · 98% confidence The document is a 'Notification from person discharging managerial responsibilities' regarding the execution of a Stock Grant Program, referencing Article 19 of MAR (Market Abuse Regulation). This type of filing specifically details personal share transactions by executives or board members. This aligns directly with the definition of Director's Dealing (DIRS). Although it mentions an attachment, the core content is the insider transaction disclosure, making DIRS more specific than a general RPA or RNS.
2023-08-25 English
Powiadomienie od osoby pełniącej obowiązki zarządcze w Spółce w związku z realizacją Programu Motywacyjnego - art. 19 MAR / Notification from person discharging managerial responsibilities in the C...
Remuneration Information Classification · 99% confidence The document text is very short (524 characters) and explicitly states that the content of a notification (received under MAR Regulation, Article 19(1)) regarding a transaction by a Supervisory Board member (Paweł Przewięźlikowski) is attached as an appendix to the current report. This structure—announcing receipt of a transaction report by an insider/manager and attaching the actual report—is characteristic of insider dealing disclosures. The specific category for director/executive share transactions is 'Director's Dealing' (DIRS). Although it is an announcement, the core subject matter is the director's dealing, which is a more specific classification than the general 'RPA' or 'RNS' fallback.
2023-08-25 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.